Rock Springs Capital Management LP - Q1 2011 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q1 2011
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTUITIVE SURGICAL INC43Q2 20244.0%
NEUROCRINE BIOSCIENCES INC42Q2 20244.8%
PACIRA PHARMACEUTICALS INC42Q2 20242.6%
ULTRAGENYX PHARMACEUTICAL IN42Q2 20242.4%
ACADIA HEALTHCARE COMPANY IN41Q2 20244.4%
ASCENDIS PHARMA A/S38Q2 20241.3%
BIOMARIN PHARMACEUTICAL INC38Q2 20241.3%
MACROGENICS INC38Q2 20240.5%
AMICUS THERAPEUTICS INC37Q2 20240.6%
ADAPTIMMUNE THERAPEUTICS PLC37Q2 20241.2%

View Rock Springs Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rock Springs Capital Management LP Q1 2011 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Travere Therapeutics, Inc.May 01, 20244,411,9835.8%
Xilio Therapeutics, Inc.April 05, 20243,003,2598.7%
Aclaris Therapeutics, Inc.February 14, 20242,998,4954.2%
AGIOS PHARMACEUTICALS, INC.February 14, 20242,152,1733.8%
Gamida Cell Ltd.Sold outFebruary 14, 202400.0%
Immunocore Holdings plcFebruary 14, 20242,661,5075.4%
Inozyme Pharma, Inc.February 14, 20243,681,1746.0%
Mereo BioPharma Group plcFebruary 14, 202439,919,2555.7%
SPRUCE BIOSCIENCES, INC.February 14, 20242,609,1256.4%
Spyre Therapeutics, Inc.Sold outFebruary 14, 202400.0%

View Rock Springs Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
SC 13G2024-05-01
SC 13G/A2024-04-05
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Rock Springs Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Rock Springs Capital Management LP's holdings

CSVXLS